Your account is not claimed yet. You can sign up with ORCID to claim your account.

Peter D Arkwright (P D Arkwright)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 17

Top Venues

Paediatric drugs

Clinical and experimental immunology

Journal of immunology (Baltimore, Md. : 1950)

The British journal of dermatology

University of Manchester

University of Western Australia (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Manchester Aug 1o 2002

United Kingdom

Senior Lecturer :: Paediatrics

Education History

University of Western Australia Jan 5o 1977 - Dec 16o 1983

Australia

BSC :: Medicine

Publications

Matthew Greenhawt, Sayantani B Sindher, Julie Wang, Michael O'Sullivan, George du Toit, Edwin H Kim, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D Arkwright, Philippe Bégin, Katharina Blumchen, Thierry Bourrier, Terri Brown-Whitehorn, Heather Cassell, Edmond S Chan, Christina E Ciaccio, Antoine Deschildre, Amandine Divaret-Chauveau, Stacy L Dorris, Morna J Dorsey, Thomas Eiwegger, Michel Erlewyn-Lajeunesse, David M Fleischer, Lara S Ford, Maria Garcia-Lloret, Lisa Giovannini-Chami, Jonathan O Hourihane, Nicola Jay, Stacie M Jones, Leigh Ann Kerns, Kirsten M Kloepfer, Stephanie Leonard, Guillaume Lezmi, Jay A Lieberman, Jeanne Lomas, Melanie Makhija, Christopher Parrish, Jane Peake, Kirsten P Perrett, Daniel Petroni, Wolfgang Pfützner, Jacqueline A Pongracic, Patrick Quinn, Rachel G Robison, Georgiana Sanders, Lynda Schneider, Hemant P Sharma, Juan Trujillo, Paul J Turner, Katherine Tuttle, Julia E M Upton, Pooja Varshney, Brian P Vickery, Christian Vogelberg, Brynn Wainstein, Robert A Wood, Katharine J Bee, Dianne E Campbell, Todd D Green, Rihab Rouissi, Aurélie Peillon, Henry T Bahnson, Timothée Bois, Hugh A Sampson, A Wesley Burks
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. The New England journal of medicine 388 (19) (2023)
Amy S Paller, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Mercedes E Gonzalez, Benjamin Lockshin, Zhen Chen, Ashish Bansal, Noah A Levit, Randy Prescilla
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis. Paediatric drugs (2022)
Amy S Paller, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Mercedes E Gonzalez, Benjamin Lockshin, Zhen Chen, Ashish Bansal, Noah A Levit, Randy Prescilla
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis. Paediatric drugs 25 (1) (2022)
Amy S Paller, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Mercedes E Gonzalez, Benjamin Lockshin, Zhen Chen, Ashish Bansal, Noah A Levit, Randy Prescilla
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis. Paediatric drugs 25 (1) (2022)
Amy S Paller, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Mercedes E Gonzalez, Benjamin Lockshin, Zhen Chen, Ashish Bansal, Noah A Levit, Randy Prescilla
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis. Paediatric drugs 25 (1) (2022)
Amy S Paller, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Mercedes E Gonzalez, Benjamin Lockshin, Zhen Chen, Ashish Bansal, Noah A Levit, Randy Prescilla
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis. Paediatric drugs 25 (1) (2022)
Amy S Paller, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Mercedes E Gonzalez, Benjamin Lockshin, Zhen Chen, Ashish Bansal, Noah A Levit, Randy Prescilla
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis. Paediatric drugs 25 (1) (2022)
Tom Le Voyer, Sonoko Sakata, Miyuki Tsumura, Taushif Khan, Ana Esteve-Sole, Bandar K Al-Saud, Hatice Eke Gungor, Prasad Taur, Valentine Jeanne-Julien, Mette Christiansen, Lisa-Maria Köhler, Gehad Eltayeb ElGhazali, Jérémie Rosain, Shiho Nishimura, Fumiaki Sakura, Matthieu Bouaziz, Carmen Oleaga-Quintas, Alejandro Nieto-Patlán, Àngela Deyà-Martinez, Yasemin Altuner Torun, Anna-Lena Neehus, Manon Roynard, Sefika Elmas Bozdemir, Nawal Al Kaabi, Moza Al Hassani, Irina Mersiyanova, Flore Rozenberg, Carsten Speckmann, Ina Hainmann, Fabian Hauck, Mohammed Hamdan Alzahrani, Sami Hussain Alhajjar, Saleh Al-Muhsen, Theresa Cole, Ramsay Fuleihan, Peter D Arkwright, Raffaele Badolato, Laia Alsina, Laurent Abel, Mukesh Desai, Hamoud Al-Mousa, Anna Shcherbina, Nico Marr, Stéphanie Boisson-Dupuis, Jean-Laurent Casanova, Satoshi Okada, Jacinta Bustamante
Genetic, Immunological, and Clinical Features of 32 Patients with Autosomal Recessive STAT1 Deficiency. Journal of immunology (Baltimore, Md. : 1950) (2021)
M J Cork, D Thaçi, L F Eichenfield, Peter D Arkwright, X Sun, Z Chen, Bolanle Akinlade, S Boklage, I Guillemin, M P Kosloski, M A Kamal, J T O'Malley, N Patel, N M H Graham, Ashish Bansal
Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study. The British journal of dermatology 184 (5) (2020)
Kenshiro Matsuda, Peter D Arkwright, Yasuo Mori, Masa-Aki Oikawa, Ryo Muko, Akane Tanaka, Hiroshi Matsuda
A Rapid Shift from Chronic Hyperoxia to Normoxia Induces Systemic Anaphylaxis via Transient Receptor Potential Ankyrin 1 Channels on Mast Cells. Journal of immunology (Baltimore, Md. : 1950) 205 (11) (2020)
Benjamin Martin James Shillitoe, C Bangs, D Guzman, A R Gennery, H J Longhurst, M Slatter, D M Edgar, M Thomas, A Worth, A Huissoon, Peter D Arkwright, Stephen R A Jolles, H Bourne, H Alachkar, S Savic, D S Kumararatne, Smita Y Patel, H Baxendale, S Noorani, P F K Yong, C Waruiru, V Pavaladurai, P Kelleher, R Herriot, J Bernatonienne, M Bhole, C Steele, G Hayman, A Richter, M Gompels, C Chopra, T Garcez, Matthew S Buckland
The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clinical and experimental immunology 192 (3) (2019)
M J Cork, D Thaçi, L F Eichenfield, Peter D Arkwright, T Hultsch, J D Davis, Y Zhang, X Zhu, Z Chen, M Li, M Ardeleanu, A Teper, Bolanle Akinlade, A Gadkari, Laurent Eckert, M A Kamal, M Ruddy, N M H Graham, G Pirozzi, N Stahl, A T DiCioccio, Ashish Bansal
Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension. The British journal of dermatology 182 (1) (2019)
Peter D Arkwright, Jayne MacMahon, Jennifer Koplin, Shelly Rajput, Stephanie Cross, Roisin Fitzsimons, Neil Davidson, Veena Deshpande, Naveen Rao, Colin Lumsden, David Lacy, Katrina J Allen, Gillian Vance, James Mwenechanya, Adam T Fox, Michel Erlewyn-Lajeunesse, Hitesh Mistry, Jonathan O'B Hourihane
Severity and threshold of peanut reactivity during hospital-based open oral food challenges: An international multicenter survey. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 29 (7) (2018)
Amy Wilcock, Rajia Bahri, Silvia Bulfone-Paus, Peter D Arkwright
Mast cell disorders: From infancy to maturity. Allergy 74 (1) (2018)
Delphine Cuchet-Lourenço, Davide Eletto, Changxin Wu, Vincent Plagnol, Olivier Papapietro, James Curtis, Lourdes Ceron-Gutierrez, Chris M Bacon, Scott Hackett, Badr M Rasheed Alsaleem, Mailis Maes, Miguel Gaspar, Ali Alisaac, Emma Goss, Eman AlIdrissi, Daniela Siegmund, Harald Wajant, Dinakantha Kumararatne, Mofareh S AlZahrani, Peter D Arkwright, Mario Abinun, Rainer Doffinger, Sergey Nejentsev
Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation. Science (New York, N.Y.) 361 (6404) (2018)
A Stubbs, C Bangs, B Shillitoe, J D Edgar, S O Burns, M Thomas, H Alachkar, Matthew S Buckland, E McDermott, G Arumugakani, S Jolles, R Herriot, Peter D Arkwright
Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy. Clinical and experimental immunology 191 (2) (2017)
Jonathan J Lyons, Xiaomin Yu, Jason D Hughes, Quang T Le, Ali Jamil, Yun Bai, Nancy Ho, Ming Zhao, Yihui Liu, Michael P O'Connell, Neil N Trivedi, Celeste Nelson, Thomas DiMaggio, Nina Jones, Helen Matthews, Katie L Lewis, Andrew J Oler, Ryan J Carlson, Peter D Arkwright, Celine Hong, Sherene Agama, Todd M Wilson, Sofie Tucker, Yu Zhang, Joshua J McElwee, Maryland Pao, Sarah C Glover, Marc E Rothenberg, Robert J Hohman, Kelly D Stone, George H Caughey, Theo Heller, Dean D Metcalfe, Barbara B Biesecker, Lawrence B Schwartz, Joshua D Milner
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nature genetics 48 (12) (2016)

Peter D Arkwright.css-eqlu8i{font-size:small;padding-left:4px;} (P D Arkwright)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter D Arkwright (P D Arkwright)